HeartLogic™ in Patients With Heart Failure.

Prior treatment

• Patients with a concomitant HF device other than cardiac resynchronization, such as a ventricular assist devices or cardiac contractility modulation devices;
• Participation to a concomitant study evaluating management of HF decompensation, or diuretic titration.
• Patients receiving State Medical Aid (Aide Médicale d'Etat).

Other illness

• Patients on heart transplant list, or patients with a heart transplant;

Other

• Patients not consenting and non-compliant with remote care directions.
• Patients with invasive remote HF monitoring device (such as CardioMems);
• Patients with a glomerular filtration rate \<30 ml/min/m2;
• Patients enable to consent.
• Pregnant or breastfeeding women.
• Persons benefiting from a reinforced protection, namely minors, persons deprived of liberty by a judicial or administrative decision, adults under legal protection, and finally patients in emergency situations

• Patients aged ≥18 years old;
• Patients implanted with a cardiac defibrillator for less than 6 months, with or without resynchronization, enabling the HeartLogic™ algorithm;
• Patients with a history of HF (left ventricular ejection fraction ≤40%; or at least one episode of clinical HF with NT-proBNP blood concentration ≥450 ng/L);
• Patients with New York Heart Association Class II or III HF;
• Patient able to comply with the protocol, including Latitude™ transmissions (including adequate connectivity), and study visits.
• Patients with compulsory health insurance